A Study to Assess the Efficacy and Safety of ZL-1109 in Chinese Participants With Active Thyroid Eye Disease

Abroad (travel likely)RecruitingPHASE3

Conditions

Thyroid Eye Disease (TED)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Site01006, Beijing, China

  • Site01009, Beijing, China

  • Site01010, Beijing, China

  • Site01029, Bengbu, China

  • Site01020, Changsha, China

  • Site01022, Chengdu, China

  • Site01031, Chongqing, China

  • Site01011, Dalian, China

  • Site01008, Foshan, China

  • Site01004, Fuzhou, China

  • Site01007, Guangzhou, China

  • Site01027, Guiyang, China

  • Site01018, Hangzhou, China

  • Site01002, Hefei, China

  • Site01024, Jinan, China

  • Site01005, Luoyang, China

  • Site01017, Nanchang, China

  • Site01001, Shanghai, China

  • Site01012, Shenyang, China

  • Site01023, Taiyuan, China

  • Site01013, Tianjin, China

  • Site01016, Wuxi, China

  • Site01028, Xi'an, China

  • Site01025, Xuzhou, China

  • Site01026, Yangzhou, China

  • Site01019, Zhengzhou, China

  • Site01030, Zhengzhou, China